Supraventricular Tachycardia: Difference between revisions
Jump to navigation
Jump to search
Line 1: | Line 1: | ||
==Section 4 - CARDIAC 4.07== | ==Section 4 - CARDIAC 4.07== | ||
= | ====CONSIDER MEDICAL ETIOLOGY OF SVT AND REFER TO APPROPRIATE PRACTICE PARAMETER:==== | ||
* Heart failure, [[Acute Cardiogenic Pulmonary Edema Pneumonia|PULMONARY EDEMA (4.11)]]. | |||
CONSIDER MEDICAL ETIOLOGY OF SVT AND REFER TO APPROPRIATE PRACTICE PARAMETER: | * Hypovolemia, [[Shock|SHOCK (5.13)]]. | ||
* Heart failure, [[Acute Cardiogenic Pulmonary Edema Pneumonia|PULMONARY EDEMA | |||
* Hypovolemia, [[Shock|SHOCK | |||
* Side-effects of other drugs, etc. | * Side-effects of other drugs, etc. | ||
[[Initial Medical Assessment and Care|INITIAL MEDICAL CARE (2.01)]] - OXYGEN @ 100% via NRB mask. | |||
====STABLE NARROW COMPLEX TACHYCARDIA:==== | |||
* Initiate large bore IV, preferably at antecubital fossae | |||
* Administer [[Antiarrhythmics|ADENOSINE]] 6 mg RAPID IVP, administered at a port closest to the IV site, followed immediately by a rapid 10-20 ml saline flush | |||
* If NO response in 2 minutes, [[Antiarrhythmics|ADENOSINE]] 12 mg RAPID IVP followed immediately by a rapid 10-20 ml saline flush (Maximum dose 18 mg) | |||
* Initiate large bore IV, preferably at | |||
* [[Antiarrhythmics|ADENOSINE]] 6 mg RAPID IVP, administered at a port closest to the IV site, followed immediately by a rapid 10 ml saline flush | |||
* If NO response in 2 minutes, [[Antiarrhythmics|ADENOSINE]]12 mg RAPID IVP followed immediately by a rapid 10 ml saline flush | |||
====UNSTABLE:==== | |||
{| class="wikitable" | |||
|- | |||
! Definition of Unstable: Persistent Narrow Complex Tachyarrhythmia causing: | |||
|- | |||
| | |||
*Hypotension or signs of decreased tissue perfusion | |||
*Significant dyspnea or significant compromise of the airway | |||
*Acute mental status change | |||
*Signs/symptoms of shock | |||
*Acute heart failure | |||
*Ischemic chest discomfort | |||
|} | |||
* If IV established prior to patient becoming UNSTABLE, may administer [[Antiarrhythmics|ADENOSINE]]6 mg RAPID IVP. If unrelieved, consider sedation with [[Analgesia and Sedation|VERSED (2.04)]] if patient is conscious and proceed with below therapies. | |||
** '''SYNCHRONIZED CARDIOVERSION''' | |||
*** Initial recommended doses: | |||
**** If narrow and regular complexes 50-100 Joules biphasic | |||
**** If narrow and irregular complexes 120-200 Joules biphasic | |||
**** If wide and regular complexes 100 Joules biphasic | |||
**** If wide and irregular complexes – use defibrillation dose (not synchronized) | |||
'''If | '''''Physician's Orders: If NO response, contact Medical Control for consult.''''' |
Revision as of 14:37, 3 May 2012
Section 4 - CARDIAC 4.07
CONSIDER MEDICAL ETIOLOGY OF SVT AND REFER TO APPROPRIATE PRACTICE PARAMETER:
- Heart failure, PULMONARY EDEMA (4.11).
- Hypovolemia, SHOCK (5.13).
- Side-effects of other drugs, etc.
INITIAL MEDICAL CARE (2.01) - OXYGEN @ 100% via NRB mask.
STABLE NARROW COMPLEX TACHYCARDIA:
- Initiate large bore IV, preferably at antecubital fossae
- Administer ADENOSINE 6 mg RAPID IVP, administered at a port closest to the IV site, followed immediately by a rapid 10-20 ml saline flush
- If NO response in 2 minutes, ADENOSINE 12 mg RAPID IVP followed immediately by a rapid 10-20 ml saline flush (Maximum dose 18 mg)
UNSTABLE:
Definition of Unstable: Persistent Narrow Complex Tachyarrhythmia causing: |
---|
|
- If IV established prior to patient becoming UNSTABLE, may administer ADENOSINE6 mg RAPID IVP. If unrelieved, consider sedation with VERSED (2.04) if patient is conscious and proceed with below therapies.
- SYNCHRONIZED CARDIOVERSION
- Initial recommended doses:
- If narrow and regular complexes 50-100 Joules biphasic
- If narrow and irregular complexes 120-200 Joules biphasic
- If wide and regular complexes 100 Joules biphasic
- If wide and irregular complexes – use defibrillation dose (not synchronized)
- Initial recommended doses:
- SYNCHRONIZED CARDIOVERSION
Physician's Orders: If NO response, contact Medical Control for consult.